Founder, Chairperson and CEO
Liang Schweizer is the founder, Chairperson and CEO of HiFiBiO Therapeutics, an emerging multinational biotherapeutics company with unique strengths in immune modulation and single-cell science. Previously, she co-founded Harbour Biomed as its CSO and successfully transformed an antibody platform company into a drug discovery and development enterprise. Before launching her entrepreneurial career, Liang was Head of Asian Cancer Research at Sanofi and Director of Lead Discovery and Optimization at Bristol-Myers Squibb Company.
Liang Schweizer graduated from the University of Science and Technology of China (USTC), majoring in Biology. She received her Master’s degree in Microbial Engineering at the University of Minnesota with a Minor in Chemical Engineering. Liang earned her Ph.D in Molecular Biology from the University in Zurich, Switzerland. Her postdoctoral training was with Dr. Harold Varmus, a Nobel Laureate, at Memorial Sloan Kettering Cancer Center (MSKCC), New York.